Associate Professor, Pathology, UCLA School of Medicine
Pathology
Dr. Shikha Bose, MD
|
|
Give Review
Shikha Bose works in the field of Pathology. Shikha Bose is also a published doctor. She has 14 paper published. The most recent paper is: ProEx() C is a useful ancillary study for grading anal intraepithelial neoplasia alone and in combination with other biomarkers. Shikha Bose accepts Medicare payments and is listed with Medicare.gov.
Publications
- ProEx(™) C is a useful ancillary study for grading anal intraepithelial neoplasia alone and in combination with other biomarkers.
- BRCA-mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin-like Growth Factor II mRNA-binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14.
- Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
- FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer.
- BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
- Paget's Disease of the Nipple with Parenchymal Ductal Carcinoma In Situ Is Associated with Worse Prognosis than Paget's Disease Alone.
- Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis.
- Follicular lesion of undetermined significance in thyroid FNA revisited.
- WNT10B/?-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.
- CINtec® plus dual immunostain: A triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial l...
- Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined sign...
- Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens.
- Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens.
Doctors Specialties
- Cytopathology
- Pathology
Accepted Insurances
Education
-
Memorial Sloan-Kettering Cancer Center -
Lankenau Medical Center
Hospital
-
Ronald Reagan UCLA Medical Center -
Cedars-Sinai Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497758213 |
| Last Name Of The Provider | BOSE |
| First Name Of The Provider | SHIKHA |
| View All |
Similar Doctors
|
|
Dr. Mahul B. Amin, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mariza N. De Peralta-Venturina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart B. Dubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph M. Mirra, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Daniel J. Luthringer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joanne K. Rutgers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Premi Thomas, MD |
|
|
Dr. Karen A. Scharre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna J. Xie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nasim Babaidorabad, MD |